Intersect ENT provides therapy solutions that enable ENT physicians to improve patients' quality of life.
Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose, and Throat surgeons to utilize in providing improved treatment for their patients. The company was founded in 2003 by Don Eaton and is headquartered in Menlo Park, California, United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 25, 2013 | Series D | $30M | 1 | Norwest Venture Partners | — | Detail |
Oct 28, 2010 | Series C | $31.01M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Norwest Venture Partners | Yes | Series D |
Medtronic | — | Series C |